Literature DB >> 9108092

Transgenic rescue from embryonic lethality and renal carcinogenesis in the Eker rat model by introduction of a wild-type Tsc2 gene.

T Kobayashi1, H Mitani, R Takahashi, M Hirabayashi, M Ueda, H Tamura, O Hino.   

Abstract

We recently reported that a germ-line insertion in the rat homologue of the human tuberous sclerosis gene (TSC2) gives rise to dominantly inherited cancer in the Eker rat model. In this study, we constructed transgenic Eker rats with introduction of a wild-type Tsc2 gene to ascertain whether suppression of the Eker phenotype is possible. Rescue from embryonic lethality of mutant homozygotes (Eker/Eker) and suppression of N-ethyl-N-nitrosourea-induced renal carcinogenesis in heterozygotes (Eker/+) were both observed, defining the germ-line Tsc2 mutation in the Eker rat as embryonal lethal and tumor predisposing mutation. To the best of our knowledge, this is the first report of rescue from a naturally occurring dominantly inherited cancer. This transgenic rescue system will be useful to analyze Tsc2 gene function, its relation to tumorigenesis in vivo, and genetic-environmental interactions in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9108092      PMCID: PMC20555          DOI: 10.1073/pnas.94.8.3990

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Centrosema mosaic: a plant virus disease transmitted by both aphids and plant bugs.

Authors:  R J VAN VELSEN; N C CROWLEY
Journal:  Nature       Date:  1961-03-11       Impact factor: 49.962

2.  Fertilization of rat eggs in vitro by epididymal spermatozoa and the development of eggs following transfer.

Authors:  Y Toyoda; M C Chang
Journal:  J Reprod Fertil       Date:  1974-01

3.  Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas.

Authors:  E P Henske; H P Neumann; B W Scheithauer; E W Herbst; M P Short; D J Kwiatkowski
Journal:  Genes Chromosomes Cancer       Date:  1995-08       Impact factor: 5.006

4.  Alternative splicing of the tuberous sclerosis 2 (TSC2) gene in human and mouse tissues.

Authors:  L Xu; C Sterner; M M Maheshwar; P J Wilson; M Nellist; P M Short; J L Haines; J R Sampson; V Ramesh
Journal:  Genomics       Date:  1995-06-10       Impact factor: 5.736

5.  Allelic loss at the predisposing gene locus in spontaneous and chemically induced renal cell carcinomas in the Eker rat.

Authors:  Y Kubo; H Mitani; O Hino
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

6.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

7.  Genetic predisposition to transplacentally induced renal cell carcinomas in the Eker rat.

Authors:  O Hino; H Mitani; A G Knudson
Journal:  Cancer Res       Date:  1993-12-15       Impact factor: 12.701

8.  Identification and characterization of the tuberous sclerosis gene on chromosome 16.

Authors: 
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

9.  A novel cancer predisposition syndrome in the Eker rat model.

Authors:  O Hino; H Mitani; H Katsuyama; Y Kubo
Journal:  Cancer Lett       Date:  1994-08-15       Impact factor: 8.679

10.  Allelic loss at the tuberous sclerosis (Tsc2) gene locus in spontaneous uterine leiomyosarcomas and pituitary adenomas in the Eker rat model.

Authors:  Y Kubo; Y Kikuchi; H Mitani; E Kobayashi; T Kobayashi; O Hino
Journal:  Jpn J Cancer Res       Date:  1995-09
View more
  17 in total

1.  Tuberous sclerosis.

Authors:  F J O'Callaghan
Journal:  BMJ       Date:  1999-04-17

Review 2.  Advances in the understanding of tuberous sclerosis.

Authors:  F J O'Callaghan; J P Osborne
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

3.  Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: no evidence for genotype-phenotype correlation.

Authors:  M van Slegtenhorst; S Verhoef; A Tempelaars; L Bakker; Q Wang; M Wessels; R Bakker; M Nellist; D Lindhout; D Halley; A van den Ouweland
Journal:  J Med Genet       Date:  1999-04       Impact factor: 6.318

Review 4.  Nailing down a link between tuberin and renal cysts.

Authors:  David M Hockenbery
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

5.  Identification of a leader exon and a core promoter for the rat tuberous sclerosis 2 (Tsc2) gene and structural comparison with the human homolog.

Authors:  T Kobayashi; S Urakami; J P Cheadle; R Aspinwall; P Harris; J R Sampson; O Hino
Journal:  Mamm Genome       Date:  1997-08       Impact factor: 2.957

6.  A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice.

Authors:  T Kobayashi; O Minowa; Y Sugitani; S Takai; H Mitani; E Kobayashi; T Noda; O Hino
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

7.  Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development.

Authors:  G Rennebeck; E V Kleymenova; R Anderson; R S Yeung; K Artzt; C L Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 8.  Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis.

Authors:  A C Jones; M M Shyamsundar; M W Thomas; J Maynard; S Idziaszczyk; S Tomkins; J R Sampson; J P Cheadle
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

9.  The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation.

Authors:  Q Gao; S Srinivasan; S N Boyer; D E Wazer; V Band
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

10.  Genetics and molecular biology of tuberous sclerosis complex.

Authors:  Valerio Napolioni; Paolo Curatolo
Journal:  Curr Genomics       Date:  2008-11       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.